Earnings Call · Q3 FY2022·2022-10-28

Q3 22EPS +2.52%·Rev n/aQ2 22EPS +1.81%·Rev n/aQ1 22EPS +0.64%·Rev n/aQ4 21EPS +0.91%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Vice President, Investor Relations

Rick Gonzalez — Chairman of the Board and Chief Executive Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Tom Hudson — Senior Vice President, R&D and Chief Scientific Officer

Rob Michael — Vice Chairman and President

−3.8%1d on move date−6.2% vs SPY3d−4.3%5d−5.9%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access